SCHEMBL16927240

SCHEMBL16927240

CN(C)C(=O)C[C@H](NC(=O)O)c1nc2cc(CCc3ccc4nc([C@H](CC(=O)N(C)C)NC(=O)OCc5ccccc5)[nH]c4c3)ccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 6/20 0.55
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC1 Q13547 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
CTDSP1 Q9GZU7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12798916 0.94 AAK1 (0.54) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2776828 0.90 AAK1 (0.50) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2777906 0.89 AAK1 (0.59) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2777481 0.85 AAK1 (0.56) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL16927242 0.85 AAK1 (0.56) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2777478 0.85 AAK1 (0.56) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL16927322 0.85 AAK1 (0.55) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2779233 0.85 AAK1 (0.55) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL2779366 0.84 AAK1 (0.56) AAK1HDAC3HDAC4HDAC1HDAC7
SCHEMBL12798922 0.84 AAK1 (0.55) AAK1HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318376-B1 BI-1H-BENZIMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-07-29 EP claimed
EP-2318376-B1 BI-1H-BENZIMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-07-29 EP disclosed